A 37-year-old woman was admitted after 3 days of fever, cough and diffuse pain. She had a 6-month history of relapsing polychondritis treated with steroids and, initially, cyclophosphamide. Cyclophosphamide was stopped after the third infusion due to anaphylactic shock and replaced by mycophenolate mofetil.
polychondritis-affected patients. Routine laboratory tests showed an inflammatory syndrome (CRP = 247 mg/l). Thoracic radiography was normal.
An antibiotic treatment (levofloxacine) was given during 5 days, but fever and pain did not decrease. To ensure that there was no infectious disease in this context of fever and immunodeficiency, a PET/CT was carried out and revealed no evidence of infection. However, it did reveal 18F-FDG uptake (SUV max = 4.1) on the chondro-costal junctions, tracheal rings and vocal cords ( Figure 1 ). A relapse of polychondritis was diagnosed.
After 3 days of steroid infusions (methylprednisolone 750 mg/day), fever, dyspnea, pain and dermatitis disappeared and the inflammatory syndrome decreased significantly. This patient is currently being treated by methotrexate and low-dose steroids.
Relapsing polychondritis is a rare disease in which recurrent bouts of inflammation affect the cartilage of the larynx, nose, ears and tracheobronchial tree. 1 The pathogenesis involves an autoimmune response followed by cartilage destruction. Recent studies have shown that PET/CT can be helpful for positive and differential diagnosis. [2] [3] [4] [5] Glucocorticoid therapy is the cornerstone of the treatment and is used chronically in most patients. Cyclophosphamide, azathioprine or methotrexate are used in severe forms. 
